BRAIDWELL LP

Position in HROW — Harrow, Inc.

CIK 1920938 STAMFORD, CT

Position in HROW

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,515,333

-$8,953,926 QoQ

Shares Held

156,419

-47.0% QoQ

Ownership

0.420%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BRAIDWELL LP holds $138,308,361 across 5 Drug Manufacturers - Specialty & Generic names. HROW ranks #5 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	652,121	$85,910,420
2	BIOA	BioAge Labs, Inc.	1,200,587	$20,998,266
3	KNSA	Kiniksa Pharmaceuticals International, plc	272,522	$13,121,934
4	EOLS	Evolus, Inc.	3,105,209	$12,762,408
5	HROW	Harrow, Inc. This page	156,419	$5,515,333

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,515,333	156,419	-47.0%	Shares	Sole	2026-05-15
2025-12-31	$14,469,259	295,291	-13.8%	Shares	Sole	2026-02-17
2025-09-30	$16,496,398	342,391	-60.7%	Shares	Sole	2025-11-14
2025-06-30	$26,638,392	872,246	-8.8%	Shares	Sole	2025-08-14
2025-03-31	$25,451,917	956,839	+5.5%	Shares	Sole	2025-05-15
2024-12-31	$30,431,158	907,039	+106.3%	Shares	Sole	2025-02-14
2024-09-30	$19,766,124	439,638	+47.9%	Shares	Sole	2024-11-14
2024-06-30	$6,208,257	297,188	+135.9%	Shares	Sole	2024-08-14
2024-03-31	$1,666,543	125,967	-91.6%	Shares	Sole	2024-05-15
2023-12-31	$16,784,140	1,498,584	-17.1%	Shares	Sole	2024-02-14
2023-09-30	$25,990,789	1,808,684	+24.5%	Shares	Sole	2023-11-14
2023-06-30	$27,656,323	1,452,538	0.0%	Shares	Sole	2023-08-14
2023-03-31	$30,735,704	1,452,538	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.